- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03924921
The Effectiveness of a Relaxation Technique on the Quality of Life and Symptoms in People Living With HIV
September 9, 2019 updated by: Université de Montréal
Quality of life of people living with HIV is strongly affected by the presence of one or more symptoms, such as sleep problems, fatigue, muscle pain, anxiety and depressive symptoms.
Autogenic training has shown positive effects on these symptoms in different populations, but there is very little evidence on the effects of this relaxation technique in people living with HIV.
Study Overview
Detailed Description
The aim of this project is to evaluate the effectiveness of a relaxation technique, autogenic training, on the quality of life and the physical and psychological symptoms in people living with HIV.
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H2W1T8
- CHUM
-
Montréal, Quebec, Canada, H4A3J1
- CUSM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being older than 18 ;
- have a diagnosis of HIV;
- present at least one of the following symptoms during the preceding two weeks: sleep problems, fatigue, pain, anxiety or symptoms of depression;
- understand and speak French and;
- be able to follow the instructions to learn the relaxation technique.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: autogenic training
Autogenic training
|
autogenic training
|
EXPERIMENTAL: wait list
usual care for 6 months Autogenic training after 6 months
|
autogenic training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient-Reported Outcomes Quality of Life-human immunodeficiency virus (PROQOL-HIV)
Time Frame: 3 and 6 months
|
The PROQOL-HIV questionnaire is composed of 43 Likert-type items (5-point scale ranging from 0=never to 4=always), including 39 items targeting 8 domains of HRQL and general health: physical health and symptoms (9 items), treatment impact (10 items), emotional distress (4 items), health concerns (4 items), body change (4 items), intimate relationships (3 items), social relationships (2 items), and stigma (2 items).
Four extra items dealing with religious beliefs, finance, having children, and satisfaction with care are not part of the scoring scheme, but are used to gather additional information from the respondent.
Responses to items will be totaled for each dimension and standardized on a scale from 0 to 100 points, in which higher values indicate a better health state.
|
3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 3 and 6 months
|
Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality and quantity.
The19-item self-report questionnaire yields 7 component scores: subjective sleep quality, sleep latency, duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction each weighted equally on a 0-3 scale.
The seven component scores are then summed to yield a global PSQI score, which has a range of 0-21; higher scores indicate worse sleep quality.
|
3 and 6 months
|
Fatigue Severity Scale (FSS)
Time Frame: 3 and 6 months
|
Fatigue severity scale (FSS) is a 9-items instrument with seven items related to fatigue interference, one item related to the experience of fatigue itself and one item about what causes fatigue.
Each item is scored on a 7-point Likert scale ranging from 1 (''strongly disagree'') to 7 (''strongly agree'').
The mean score of the 9 items is used to estimate fatigue severity.
|
3 and 6 months
|
Brief Pain Inventory
Time Frame: 3 and 6 months
|
Brief Pain Inventory (BPI) is a two-factor instrument that measures pain severity and pain interference.
The pain severity factor has four items, all rated on a 0 ''No pain'' to 10 ''Pain as bad as you can imagine'' Likert scale.
The pain interference factor has seven items, all rated on a 0 ''Does not interfere'' to 10 ''Interferes completely'' Likert scale.
Arithmetic mean of the four severity items can be used as measures of pain severity; the arithmetic mean of the seven interference items can be used as a measure of pain interference
|
3 and 6 months
|
State -Trait Anxiety Inventory (STAI)
Time Frame: 3 and 6 months
|
State-Trait Anxiety Inventory (STAI) is a 40-items instrument that measures state anxiety and trait anxiety.
Each type of anxiety has its own scale of 20 different questions that are scored on a 4-point Likert scale ranging from 1 "Almost never" to 4 "Almost always".
Scores range from 20 to 80, with higher scores correlating with greater anxiety.
|
3 and 6 months
|
PHQ-9
Time Frame: 3 and 6 months
|
Patient Health Questionnaire (PHQ-9) is a 9-item instrument that measure depressive symptoms severity.
PhQ-9 score ranges from 0 to 27, because each of the 9 items can be scores from 0 "not at all" to 3 "nearly every day".
Higher scores indicate higher severity.
|
3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Pilar Ramirez-Garcia, PhD, Université de Montréal
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2015
Primary Completion (ACTUAL)
June 1, 2018
Study Completion (ACTUAL)
December 1, 2018
Study Registration Dates
First Submitted
April 18, 2019
First Submitted That Met QC Criteria
April 22, 2019
First Posted (ACTUAL)
April 23, 2019
Study Record Updates
Last Update Posted (ACTUAL)
September 11, 2019
Last Update Submitted That Met QC Criteria
September 9, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2016-5940:PRG
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
Clinical Trials on autogenic training
-
University Health Network, TorontoUnilever R&DCompleted
-
Universidad Complutense de MadridCompleted
-
Aylin GüneşCompletedQuality of Life | Vasomotor SymptomsTurkey
-
University of Texas at AustinCompletedFemale Sexual Arousal DisorderUnited States
-
My Music Machines Inc.National Heart, Lung, and Blood Institute (NHLBI); Albany Medical CollegeWithdrawnCystic Fibrosis in ChildrenUnited States
-
Université de MontréalLaval University; RRISIQCompletedHIV | Depressive SymptomsCanada
-
Riphah International UniversityCompleted
-
University School of Physical Education in WroclawFoundation for Senior Citizen Activation SIWY DYMCompletedCardiovascular Diseases | Coronary Artery Disease | Mood Disorders | Stress | Anxiety | Depressive SymptomsPoland
-
Cliniques universitaires Saint-Luc- Université...Recruiting
-
University of Warsaw, PolandDuke UniversityRecruiting